• Home
  • Search Results
  • C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration.

C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration.

Acta neuropathologica (2014-08-15)
Stephanie May, Daniel Hornburg, Martin H Schludi, Thomas Arzberger, Kristin Rentzsch, Benjamin M Schwenk, Friedrich A Grässer, Kohji Mori, Elisabeth Kremmer, Julia Banzhaf-Strathmann, Matthias Mann, Felix Meissner, Dieter Edbauer
ABSTRACT

Hexanucleotide repeat expansion in C9orf72 is the most common pathogenic mutation in patients with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Despite the lack of an ATG start codon, the repeat expansion is translated in all reading frames into dipeptide repeat (DPR) proteins, which form insoluble, ubiquitinated, p62-positive aggregates that are most abundant in the cerebral cortex and cerebellum. To specifically analyze DPR toxicity and aggregation, we expressed DPR proteins from synthetic genes containing a start codon but lacking extensive GGGGCC repeats. Poly-Gly-Ala (GA) formed p62-positive cytoplasmic aggregates, inhibited dendritic arborization and induced apoptosis in primary neurons. Quantitative mass spectrometry analysis to identify poly-GA co-aggregating proteins revealed a significant enrichment of proteins of the ubiquitin-proteasome system. Among the other interacting proteins, we identified the transport factor Unc119, which has been previously linked to neuromuscular and axonal function, as a poly-GA co-aggregating protein. Strikingly, the levels of soluble Unc119 are strongly reduced upon poly-GA expression in neurons, suggesting a loss of function mechanism. Similar to poly-GA expression, Unc119 knockdown inhibits dendritic branching and causes neurotoxicity. Unc119 overexpression partially rescues poly-GA toxicity suggesting that poly-GA expression causes Unc119 loss of function. In C9orf72 patients, Unc119 is detectable in 9.5 % of GA inclusions in the frontal cortex, but only in 1.6 % of GA inclusions in the cerebellum, an area largely spared of neurodegeneration. A fraction of neurons with Unc119 inclusions shows loss of cytosolic staining. Poly-GA-induced Unc119 loss of function may thereby contribute to selective vulnerability of neurons with DPR protein inclusions in the pathogenesis of C9orf72 FTLD/ALS.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Anti-HA antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-HA antibody produced in mouse, clone HA-7, purified from hybridoma cell culture
Sigma-Aldrich
Monoclonal Anti-c-Myc antibody produced in mouse, clone 9E10, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-HA antibody produced in mouse, clone HA-7, ascites fluid
Sigma-Aldrich
Monoclonal Anti-MAP2 antibody produced in mouse, ascites fluid, clone HM-2
Sigma-Aldrich
Anti-c-Myc antibody produced in rabbit, ~0.5 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-V5 antibody, Mouse monoclonal, clone V5-10, purified from hybridoma cell culture
Sigma-Aldrich
Anti-MAP2 antibody, Mouse Monoclonal, clone HM-2, purified from hybridoma cell culture
Sigma-Aldrich
Monoclonal Anti-MAP2 (2a+2b) antibody produced in mouse, clone AP-20, ascites fluid
Sigma-Aldrich
Anti-V5 antibody produced in rabbit, IgG fraction of antiserum
Sigma-Aldrich
Monoclonal Anti-c-Myc antibody produced in mouse, clone 9E10, ascites fluid
Sigma-Aldrich
Anti-MAP2 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-PSD95 antibody produced in mouse, clone 7E3-1B8, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-MAP2 (2a+2b) antibody produced in mouse, ~2 mg/mL, clone AP-20, purified from hybridoma cell culture
Sigma-Aldrich
Anti-MAP2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-MAP2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-MYC, (N-terminal) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Monoclonal Anti-c-Myc antibody produced in mouse, clone 1A6, purified immunoglobulin, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-MYC (Ab-58) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-PSMC2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Monoclonal Anti-DLG4 antibody produced in mouse, clone 7E3, 1 mg/mL, purified immunoglobulin
Sigma-Aldrich
Monoclonal Anti-HA antibody produced in mouse, clone 1B8, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-HA antibody produced in mouse, clone 4D4, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-HA antibody produced in mouse, clone 1F7, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-HA antibody produced in mouse, clone 3C6, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-HA antibody produced in mouse, clone 3F6, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-NUP62 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution